Epilepsy due to a cortical malformation in a Neurofibromatosis type 1 patient  by Runke, Meridith & Salanova, Vicenta
Seizure 22 (2013) 476–479Case report
Epilepsy due to a cortical malformation in a Neuroﬁbromatosis type 1 patient
Meridith Runke *, Vicenta Salanova
Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Contents lists available at SciVerse ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eizA R T I C L E I N F O
Article history:
Received 5 October 2012
Received in revised form 26 February 2013
Accepted 28 February 2013Neuroﬁbromatosis 1, an autosomal dominant neurocutaneous
disorder characterized by cafe´-au-lait macules, Lisch nodules,
neuroﬁbromas, and learning disabilities, affects approximately 1 in
3000 people.1 Unlike other neurocutaneous disorders such as
tuberous sclerosis, epilepsy is not a common clinical feature,
occurring in 3.8–7% of NF1 patients.2 Rarely, case reports have
described patients with NF1 and epilepsy due to malformations of
cortical development. The types of malformations have included
hemimegalencephaly, cerebellar leptomeningeal heterotopias,
transmantle cortical dysplasia, periventricular band of heterotopic
gray matter, pachygyria, occipital encephalocele, and unilateral as
well as bilateral polymicrogyria.3 We report an additional case of
epilepsy in a Neuroﬁbromatosis 1 patient with heterotopic gray
matter and closed-lip schizencephaly.
1. Case report
The patient is a 23-year-old woman with an identical twin
sister, who was born spontaneously to healthy nonconsanguineous
parents. Cafe´ au lait macules were noted as a young child. At age
14, she began having migraine headaches, and an MRI scan was
completed, revealing a right temporal lobe abnormality. The
neurologist treating her migraines suspected Neuroﬁbromatosis
based on cutaneous manifestations. At age 15, genetic testing was
ordered. Molecular analysis of the NF1 gene was performed via
protein truncation assay and was positive for a protein truncation
in segment 4 of the NF1 gene.
She began having seizures shortly thereafter. She had one
isolated generalized tonic clonic seizure but frequent staring spells
and confusional arousals. The staring spells typically lasted one
minute and were described as disorientation and stuttering speech* Corresponding author at: 355 W. 16th Street, Goodman Hall 4215, Indianapolis,
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http://dx.doi.org/10.1016/j.seizure.2013.02.019with postictal nausea and headaches. These were refractory to
oxcarbazepine, lamotrigine, and most recently levetiracetam,
occurring several times per week despite good compliance and
medication levels. She was hence referred to the Indiana University
epilepsy clinic for further management.
Past medical history is signiﬁcant for Neuroﬁbromatosis type 1,
migraine headaches, and seizure disorder as described.
There was no history of febrile seizures, head injury, or central
nervous system infection.
Family history was remarkable for an identical twin sister who
also has migraine headaches and NF1 but no known seizure
history. She has not yet undergone imaging. There is otherwise no
family history of NF1, including either parent.
The patient overall met developmental milestones appropri-
ately, but did require special education classes in junior and senior
high school. She does not currently work. She lives with her 8-
month-old son and boyfriend.
On physical exam, the patient had cafe´ au lait macules over the
right lateral aspect of her neck and right torso as well as scarce
bilateral axillary freckling. Otherwise, there were no stigmata of
NF1. Neurologic exam was normal.
A 3-T MRI scan demonstrated gray–white matter disorganiza-
tion in the posterior right temporal parietal lobes with suggestion
of closed lip schizencephaly and heterotopic gray matter (Fig. 1).
Video EEG demonstrated frequent right mid-posterior temporal
spike and slow-wave discharges as well as paroxysms of sharply
contoured beta frequency activity with a broad ﬁeld of distribution
over the right hemisphere (Fig. 2a).
One electrographic seizure was recorded characterized by 2 Hz
rhythmic spike and wave discharges from the right mid/poster-
otemporal region with evolution over 50 s (Fig. 2b). Clinically this
event occurred out of sleep. The patient demonstrated an alerting
response, appeared confused, and then returned to sleep immedi-
ately afterwards.
PET scan demonstrated the heterotopic gray matter but no
signiﬁcant decrease in PET uptake (Fig. 3a and b).
2. Discussion
Several features of interest differentiate our case from similar
cases previously reported. In Vivarelli et al’s retrospective analysis,
3 of 198 patients with NF1 were found to have epilepsy and
malformations of cortical development.2 A more detailed review of
these patients revealed that all three had severe mental retardation
with an IQ below 45.4 Despite her extensive MRI and EEGvier Ltd. All rights reserved.
Fig. 1. 3 T MRI demonstrating gray–white disorganization, clozed-lip schizencephaly, and heterotopic gray matter. (a and b) Axial ﬂair images; (c–e) coronal ﬂair images.
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school with only some assistance from special education, and is
raising a son. In addition, Vivarelli’s three patients all began having
seizures in infancy or early childhood, between 2 months and 13
months of age,4 while our patient did not develop seizures until
adolescence. Mastrangelo et al. reported a patient with NF1 and a
complex epileptic syndrome due to bilateral polymicrogyria with a
normal IQ of 98.5 However, her additional NF1 stigmata were
multiple, including cafe´-au-lait spots, freckling, cutaneous neuro-
ﬁbromas, a patent ventricular septum, lumbar kyphosis, and
hypertelorism.5 Other than epilepsy, our patient has minimal
clinical features of NF1, including only cafe´-au-lait spots and
axillary freckling. Finally, each of these patients had a different
type of cortical malformation. These differences highlight the
clinical hetereogeneity of NF1, even among those patients with
epilepsy and malformations of cortical development.Nevertheless, this small group of reported cases share some
features in common with our patient. All of these patients with
NF1, malformations of cortical development, and epilepsy had
medically refractory seizures. While Mastrangelo’s patient was
seizure-free at the time of publication, she had suffered several
episodes of prolonged partial status epilepticus.5 Similarly, our
patient continues to have several seizures per week despite trials
on several ﬁrst-line anti-epileptic medications. In addition, all of
these reported patients had complex partial seizures, similar to our
patient. Finally, all had EEG abnormalities which were focal or
multifocal in distribution, similar to our patient, whose interictal
and ictal EEG abnormalities involved the right mid-posterior
temporal region.
This additional case report of a patient with NF1, epilepsy, and a
malformation of cortical development supports the hypothesis of
previous authors that these clinical features may not be an
Fig. 2. (a) Interictal right mid-posterior temporal abnormalities. (b) Seizure onset from same region.
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of the NF1 protein, neuroﬁbromin, in development of the normal
nervous system.6 NF1 knock-out mice have abnormal cortical
lamination, smaller brain cortices, and increased astrogliosis.6
Therefore, it follows that the abnormal neuroﬁbromin protein inFig. 3. (a) PET scan, axial. patients with NF1 could lead to cortical malformations like those
reported and resultant epilepsy.
In summary, while epilepsy is less common in patients with
NF1 than in other neurocutaneous disorders, brain imaging is
particularly revealing to separate cortical malformations from(b) PET scan, coronal.
M. Runke, V. Salanova / Seizure 22 (2013) 476–479 479other structural etiologies. As mentioned, this subgroup of patients
may be heterogeneous in their clinical manifestations, but tend to
have medically refractory complex partial seizures.
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